Onco360 Specialty Pharmacy of the Year Finalist
Managed Markets Insight and Technology (MMIT), the leading go-to-market partner to pharma companies, payers, and providers, recognized Onco360’s commitment to our patients and selected us as a finalist of “Patient Choice Specialty Pharmacy of the Year.”
Each year, MMIT recognizes leading specialty pharmacies that are dedicated to providing best-in-class customer satisfaction for patients. The finalist and winner of Specialty Pharmacy of the Year are based on Net Provider Score (NPS) from the Zitter Insights Specialty Pharmacy Patient Satisfaction Survey. This survey provides data based on patient feedback measuring customer satisfaction.
“We’re thrilled to once again recognize those who are leading the pack in the specialty pharmacy industry,” said MMIT CEO, Mike Gallup. “2020 was a challenging year, but these organizations demonstrated an unwavering commitment to their patients. Congratulations to all of the finalists.”
“Onco360 strives to improve the lives of patients battling cancer by using our innovative, patient-centric approach to provide service excellence to our patients, their families, and healthcare providers,” says Christopher Urban, Chief Pharmacy Officer. “This selection reaffirms our commitment to our patients and the Onco360 mission. Onco360 is honored to be named as a finalist once again.”
The winners will be announced during an awards ceremony hosted by MMIT at the Asembia Specialty Pharmacy Summit in Las Vegas, October 26-29, 2021.